St Charles Cancer Center, Bend, OR, USA.
School of Medicine, University of California, San Francisco, CA, USA.
Am J Surg. 2022 Apr;223(4):699-704. doi: 10.1016/j.amjsurg.2021.05.021. Epub 2021 Jun 10.
Surgical treatment of invasive lobular carcinoma (ILC) is challenging due to its diffuse growth pattern, and the positive margin rate after mastectomy is poorly described.
We retrospectively determined the positive margin rate in those with stage I-III ILC undergoing mastectomy. We evaluated the relationship between management strategy and recurrence free survival (RFS).
In 357 patients, the positive margin rate was 10.6% overall and 18.7% in those with T3 tumors. Having a positive margin was associated with significantly shorter RFS on multivariate analysis (p = 0.01). Undergoing additional local treatment (radiation or re-excision) for a positive margin was significantly associated with improved RFS (p = 0.004). Older women with positive margins were significantly less likely to undergo additional local therapy.
Even mastectomy fails to clear margins in a high proportion of patients with large ILC tumors, a finding which may warrant testing neoadjuvant strategies even prior to planned mastectomy.
由于浸润性小叶癌(ILC)呈弥漫性生长模式,因此手术治疗具有挑战性,且乳房切除术的阳性切缘率描述不佳。
我们回顾性确定了接受乳房切除术的 I 期至 III 期 ILC 患者的阳性切缘率。我们评估了管理策略与无复发生存率(RFS)之间的关系。
在 357 例患者中,总体阳性切缘率为 10.6%,T3 肿瘤患者的阳性切缘率为 18.7%。多因素分析显示,阳性切缘与 RFS 显著缩短相关(p=0.01)。对于阳性切缘,行额外局部治疗(放疗或再次切除)与 RFS 显著改善相关(p=0.004)。阳性切缘的老年女性接受额外局部治疗的可能性明显降低。
即使是乳房切除术也未能在很大一部分大 ILC 肿瘤患者中清除切缘,这一发现可能需要检测新辅助策略,甚至在计划进行乳房切除术之前。